The Record

The Orders Library

Name: The COVID Project Orders Library
Creator: The COVID Project

13,511 instruments indexed by The COVID Project: the orders of the fifty States and the District, forty metros, the federal layer and the agencies; the standing duties; the organizers' notices; the legal authorities. Filter by kind, State, limitation type, quarter and more; open the exhibit; download what you find.

Double quotes make a phrase ("stay at home"). An exhibit ID (TX-004) opens its record first.

The COVID Projectcovidproject.com/library

Filters:Agency cluster: Other federal health agencies From Apr. 4, 2020 Clear all

46 instruments · showing 1–25

Sort Per page

Exhibit	Instrument	Issuer	Jurisdiction	Issued	Quarters	Limitations	Grade
Ex. AGY-FED-HEALTH-OTHER-076	Update on COVID-19 and Home Confinement (Apr. 5, 2020)Update on COVID-19 and Home Confinement: BOP continuing to aggressively screen potential inmates	Federal Bureau of Prisons	United States (federal); Federal Bureau of PrisonsFederal	Apr. 5, 2020	2020 Q2	Other	Primary source read
Ex. AGY-FED-HEALTH-OTHER-016	DEA-DC-025 (DEA078), Dear Registrant letter permitting opioid treatment programs to use the same off-site location repeatedly to deliver take-home methadone doses without separate registrationOff-site OTP delivery method (Final)	Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Apr. 7, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-003	Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 29637 (May 18, 2020)Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency	Roger T. Severino, Director, Office for Civil Rights, HHS	United States (federal); Department of Health and Human Services, Office for Civil RightsFederal	Apr. 9, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-053	Emergency Use Authorization: Face Shields (umbrella) (issued Apr. 9, 2020; amended Apr. 13, 2020)Letter of Authorization, Face Shields (Apr. 13, 2020)	Denise M. Hinton, Chief Scientist, FDA	United States (federal); Food and Drug AdministrationFederal	Apr. 13, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-017	DEA-DC-027 (DEA083), letter to DEA-registered distributors and manufacturers granting an exception to the signed-delivery requirement for narcotic shipments to narcotic treatment programsDEA Dist/MNF narcotics shipments to OTP signed delivery exception (final)	William T. McDermott, Assistant Administrator, Diversion Control Division, DEA	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Apr. 10, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Supply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-018	DEA-DC-028 (DEA084), letter permitting DEA-registered hospitals and clinics to handle controlled substances at satellite locations under the existing registration during the COVID-19 emergencyHospital/Clinic Registration Exception (final)	William T. McDermott, Assistant Administrator, Diversion Control Division, DEA	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Apr. 10, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-118	Provider Relief Fund, Acceptance of Terms and Conditions, Relief Fund Payment from Initial $30 Billion General DistributionAcceptance of Terms and Conditions - Relief Fund Payment from Initial $30 Billion General Distribution	Secretary of Health and Human Services (terms administered by HRSA)	United States (federal); Department of Health and Human Services (Health Resources and Services Administration administering the Provider Relief Fund)Federal	Apr. 10, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-019	DEA-DC-029 (DEA085), letter granting a temporary exception to the five percent rule for practitioners distributing controlled substances to other registrants during the COVID-19 emergencyDEA 5 percent practitioner exception (final)	William T. McDermott, Assistant Administrator, Diversion Control Division, DEA	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Apr. 13, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-020	DEA-DC-030 (DEA087), letter extending the off-site take-home delivery flexibility to buprenorphine dispensed by opioid treatment programsOff site OTP delivery buprenorphine	Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Apr. 21, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-025	FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergencyFAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency	SAMHSA, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies	United States (federal); Department of Health and Human Services, Substance Abuse and Mental Health Services AdministrationFederal	Apr. 21, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-033	Notice, Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability, 85 Fed. Reg. 27987 (May 12, 2020)Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability	Food and Drug Administration, HHS	United States (federal); Food and Drug AdministrationFederal	May 12, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-077	COVID-19 Action Plan: Phase Seven (ordered May 18, 2020): all Phase Six measures extended through June 30, 2020COVID-19 Action Plan: Phase Seven - Agency-wide measures extended	Director, Federal Bureau of Prisons	United States (federal); Federal Bureau of PrisonsFederal	May 20, 2020	2020 Q2	Business closureGathering capTravel and quarantineQuarantine and isolation	Primary source read
Ex. AGY-FED-HEALTH-OTHER-054	Emergency Use Authorization: Gowns and Other Apparel (umbrella) (May 22, 2020)Letter of Authorization, Gowns and Other Apparel	Denise M. Hinton, Chief Scientist, FDA	United States (federal); Food and Drug AdministrationFederal	May 22, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-063	Interim Final Rule, Informed Consent and Advance Directives, 85 Fed. Reg. 31698 (May 27, 2020)Informed Consent and Advance Directives	Department of Veterans Affairs	United States (federal); Department of Veterans AffairsFederal	May 27, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Telework mandateHealth care orders	Primary source read
Ex. AGY-FED-HEALTH-OTHER-035	Notice, Process for Publishing Emergency Use Authorizations for Medical Devices During Coronavirus Disease 2019, 85 Fed. Reg. 33686 (June 2, 2020)Process for Publishing Emergency Use Authorizations for Medical Devices During Coronavirus Disease 2019	Food and Drug Administration, HHS	United States (federal); Food and Drug AdministrationFederal	June 2, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Other	Primary source read
Ex. AGY-FED-HEALTH-OTHER-034	Notice, Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability, 85 Fed. Reg. 34638 (June 5, 2020)Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability	Food and Drug Administration, HHS	United States (federal); Food and Drug AdministrationFederal	June 5, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-062	Interim Final Rule, Home Visits in Program of Comprehensive Assistance for Family Caregivers During COVID-19 National Emergency, 85 Fed. Reg. 34523 (June 5, 2020)Home Visits in Program of Comprehensive Assistance for Family Caregivers During COVID-19 National Emergency	Department of Veterans Affairs	United States (federal); Department of Veterans AffairsFederal	June 5, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Telework mandateHealth care orders	Primary source read
Ex. AGY-FED-HEALTH-OTHER-071	Final Rule, Video Visiting and Telephone Calls Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 85 Fed. Reg. 37331 (June 22, 2020)Video Visiting and Telephone Calls Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act	Bureau of Prisons, Department of Justice (Michael Carvajal, Director)	United States (federal); Department of Justice, Federal Bureau of PrisonsFederal	June 22, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Gathering capOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-021	DEA-DC-043 (EO-DEA213), guidance: Administering certain controlled substances in the parking lot of a health care provider's DEA-registered location during the COVID-19 public health emergencyAdministering Certain CS in the parking lot of a healthcare provider's DEA-registered location during the COVID-19 public health emergency	Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA213)	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	July 28, 2020	2020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-022	DEA-DC-044 (EO-DEA192), guidance: Telemedicine and separate State registrationTelemedicine: Will I need to hold a separate DEA registration in the state where my patients are located?	Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA192)	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	July 28, 2020	2020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Telework mandateHealth care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-055	Emergency Use Authorization: Surgical Masks (umbrella) (issued Aug. 5, 2020; reissued Mar. 6, 2023)Letter of Authorization, Surgical Masks (reissued Mar. 6, 2023)	Food and Drug Administration (Office of the Chief Scientist)	United States (federal); Food and Drug AdministrationFederal	Mar. 6, 2023	2020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-084	Interim Final Rule, Waiver of Recovery of Certain Overpayment Debts Accruing During the COVID-19 Pandemic Period, 85 Fed. Reg. 52909 (Aug. 27, 2020)Waiver of Recovery of Certain Overpayment Debts Accruing During the COVID-19 Pandemic Period	Social Security Administration (Andrew Saul, Commissioner)	United States (federal); Social Security AdministrationFederal	Aug. 27, 2020	2020 Q32020 Q4	Telework mandateOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-099	Notice, Agency Information Collection Activities: Supplemental Nutrition Assistance Program Emergency Allotments (COVID-19), 85 Fed. Reg. 52940 (Aug. 27, 2020)Agency Information Collection Activities: Supplemental Nutrition Assistance Program Emergency Allotments (COVID-19)	Food and Nutrition Service, USDA	United States (federal); Department of Agriculture, Food and Nutrition ServiceFederal	Aug. 27, 2020	2020 Q3	Emergency declarationOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-100	Notice, Agency Information Collection Activities: FNS Information Collection Needs due to COVID-19, 85 Fed. Reg. 52938 (Aug. 27, 2020)Agency Information Collection Activities: FNS Information Collection Needs due to COVID-19	Food and Nutrition Service, USDA	United States (federal); Department of Agriculture, Food and Nutrition ServiceFederal	Aug. 27, 2020	2020 Q3	Schools and child careOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-078	Bureau to Resume Social Visitation: non-contact social visits to resume Oct. 3, 2020 under Phase Nine modifications (Sept. 30, 2020)Bureau to Resume Social Visitation - Non-contact social visits to resume October 3rd	Federal Bureau of Prisons	United States (federal); Federal Bureau of PrisonsFederal	Sept. 30, 2020	2020 Q42021 Q12021 Q22021 Q3	Capacity limitGathering capFace-covering requirementQuarantine and isolation	Primary source read

Federal Bureau of Prisons, Update on COVID-19 and Home Confinement (Apr. 5, 2020) (Ex. AGY-FED-HEALTH-OTHER-076)
Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA, DEA-DC-025 (DEA078), Dear Registrant letter permitting opioid treatment programs to use the same off-site location repeatedly to deliver take-home methadone doses without separate registration (Apr. 7, 2020) (Ex. AGY-FED-HEALTH-OTHER-016)
Roger T. Severino, Director, Office for Civil Rights, HHS, Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 29637 (May 18, 2020) (Apr. 9, 2020) (Ex. AGY-FED-HEALTH-OTHER-003)
Denise M. Hinton, Chief Scientist, FDA, Emergency Use Authorization: Face Shields (umbrella) (issued Apr. 9, 2020; amended Apr. 13, 2020) (Ex. AGY-FED-HEALTH-OTHER-053)
William T. McDermott, Assistant Administrator, Diversion Control Division, DEA, DEA-DC-027 (DEA083), letter to DEA-registered distributors and manufacturers granting an exception to the signed-delivery requirement for narcotic shipments to narcotic treatment programs (Apr. 10, 2020) (Ex. AGY-FED-HEALTH-OTHER-017)
William T. McDermott, Assistant Administrator, Diversion Control Division, DEA, DEA-DC-028 (DEA084), letter permitting DEA-registered hospitals and clinics to handle controlled substances at satellite locations under the existing registration during the COVID-19 emergency (Apr. 10, 2020) (Ex. AGY-FED-HEALTH-OTHER-018)
Secretary of Health and Human Services (terms administered by HRSA), Provider Relief Fund, Acceptance of Terms and Conditions, Relief Fund Payment from Initial $30 Billion General Distribution (Apr. 10, 2020) (Ex. AGY-FED-HEALTH-OTHER-118)
William T. McDermott, Assistant Administrator, Diversion Control Division, DEA, DEA-DC-029 (DEA085), letter granting a temporary exception to the five percent rule for practitioners distributing controlled substances to other registrants during the COVID-19 emergency (Apr. 13, 2020) (Ex. AGY-FED-HEALTH-OTHER-019)
Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA, DEA-DC-030 (DEA087), letter extending the off-site take-home delivery flexibility to buprenorphine dispensed by opioid treatment programs (Apr. 21, 2020) (Ex. AGY-FED-HEALTH-OTHER-020)
SAMHSA, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies, FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency (Apr. 21, 2020) (Ex. AGY-FED-HEALTH-OTHER-025)
Food and Drug Administration, HHS, Notice, Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability, 85 Fed. Reg. 27987 (May 12, 2020) (Ex. AGY-FED-HEALTH-OTHER-033)
Director, Federal Bureau of Prisons, COVID-19 Action Plan: Phase Seven (ordered May 18, 2020): all Phase Six measures extended through June 30, 2020 (May 20, 2020) (Ex. AGY-FED-HEALTH-OTHER-077)
Denise M. Hinton, Chief Scientist, FDA, Emergency Use Authorization: Gowns and Other Apparel (umbrella) (May 22, 2020) (Ex. AGY-FED-HEALTH-OTHER-054)
Department of Veterans Affairs, Interim Final Rule, Informed Consent and Advance Directives, 85 Fed. Reg. 31698 (May 27, 2020) (Ex. AGY-FED-HEALTH-OTHER-063)
Food and Drug Administration, HHS, Notice, Process for Publishing Emergency Use Authorizations for Medical Devices During Coronavirus Disease 2019, 85 Fed. Reg. 33686 (June 2, 2020) (Ex. AGY-FED-HEALTH-OTHER-035)
Food and Drug Administration, HHS, Notice, Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability, 85 Fed. Reg. 34638 (June 5, 2020) (Ex. AGY-FED-HEALTH-OTHER-034)
Department of Veterans Affairs, Interim Final Rule, Home Visits in Program of Comprehensive Assistance for Family Caregivers During COVID-19 National Emergency, 85 Fed. Reg. 34523 (June 5, 2020) (Ex. AGY-FED-HEALTH-OTHER-062)
Bureau of Prisons, Department of Justice (Michael Carvajal, Director), Final Rule, Video Visiting and Telephone Calls Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 85 Fed. Reg. 37331 (June 22, 2020) (Ex. AGY-FED-HEALTH-OTHER-071)
Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA213), DEA-DC-043 (EO-DEA213), guidance: Administering certain controlled substances in the parking lot of a health care provider's DEA-registered location during the COVID-19 public health emergency (July 28, 2020) (Ex. AGY-FED-HEALTH-OTHER-021)
Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA192), DEA-DC-044 (EO-DEA192), guidance: Telemedicine and separate State registration (July 28, 2020) (Ex. AGY-FED-HEALTH-OTHER-022)
Food and Drug Administration (Office of the Chief Scientist), Emergency Use Authorization: Surgical Masks (umbrella) (issued Aug. 5, 2020; reissued Mar. 6, 2023) (Ex. AGY-FED-HEALTH-OTHER-055)
Social Security Administration (Andrew Saul, Commissioner), Interim Final Rule, Waiver of Recovery of Certain Overpayment Debts Accruing During the COVID-19 Pandemic Period, 85 Fed. Reg. 52909 (Aug. 27, 2020) (Ex. AGY-FED-HEALTH-OTHER-084)
Food and Nutrition Service, USDA, Notice, Agency Information Collection Activities: Supplemental Nutrition Assistance Program Emergency Allotments (COVID-19), 85 Fed. Reg. 52940 (Aug. 27, 2020) (Ex. AGY-FED-HEALTH-OTHER-099)
Food and Nutrition Service, USDA, Notice, Agency Information Collection Activities: FNS Information Collection Needs due to COVID-19, 85 Fed. Reg. 52938 (Aug. 27, 2020) (Ex. AGY-FED-HEALTH-OTHER-100)
Federal Bureau of Prisons, Bureau to Resume Social Visitation: non-contact social visits to resume Oct. 3, 2020 under Phase Nine modifications (Sept. 30, 2020) (Ex. AGY-FED-HEALTH-OTHER-078)

The Orders Library

Results